Respiratory distress syndrome in the adult after cardiopulmonary bypass. A successful therapeutic approach.
D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004417:Dyspnea / Q000175:diagnosis; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D006985:Hyperventilation / Q000175:diagnosis; D000860:Hypoxia / Q000175:diagnosis; D007231:Infant, Newborn; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D010102:Oxygen Inhalation Therapy; D011175:Positive-Pressure Respiration; D011183:Postoperative Complications; D011859:Radiography; D012127:Respiratory Distress Syndrome, Newborn / Q000209:etiology; D012131:Respiratory Insufficiency / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D012907:Smoking / Q000150:complications; D013577:Syndrome; D013997:Time Factors
D000900:Anti-Bacterial Agents; D005665:Furosemide; D006854:Hydrocortisone